Assessing Awareness and Utilization of Preventive Services, Complications, and Risk Factors Among Diabetic Patients in Jeddah, Saudi Arabia
Preventive Services among Diabetic Patients
DOI:
https://doi.org/10.54393/pjhs.v4i06.841Keywords:
Preventive services, Complications, Risk Factors, Awareness, DiabetesAbstract
Preventive care measurements such as vaccinations and health procedures play a significant part in controlling complications and reducing risk factors in diabetic patients. Objectives: To assess awareness and utilization of proven preventive services in diabetic patients and to assess complications and risk factors in diabetic patients. Methods: This was a cross-sectional survey study conducted among diabetic patients in Jeddah, Saudi Arabia. The study setting was Primary Health Care Centers in Jeddah Saudi Arabia. The study duration was from November 2018 to January 2020. Data were collected by volunteer students, interns and doctors who were trained for interviews using the questionnaire that was specifically designed for this study. 623 participants were included in the study fulfilling the criteria. The demographic details, complications, risk factors, and assessment of preventive service use among diabetic patients were summarized using descriptive statistics. Results: Out of 623 participants, 253 received influenza vaccine, 93 participants received pneumococcal vaccine, 94 participants received Meningococcal vaccine and 60 participants received DTAP vaccine with p-value <0.001. 75 participants had done mammograms, 51 people had done colonoscopy, 65 participants had done fecal occult blood and 37 participants had done Prostate-specific antigen procedure with p-value <0.001. Hypertension was present in the majority of participants accessed by physicians. Conclusions: Overall, the study's findings show that diabetic patients need to be more aware of and more likely to use preventative care. The low rates of vaccines and preventive procedures point to a potential weakness in patient education and healthcare delivery.
References
International Diabetes Federation. IDF Diabetes Atlas, 9th edition. 2020. [Last cited: 7th Jun 2023]. Available at: https://diabetesatlas.org/atlas/ninth-edition/.
Alhowaish AK. Economic costs of diabetes in Saudi Arabia. Journal of Family & Community Medicine. 2013 Jan; 20(1): 1. doi: 10.4103/2230-8229.108174. DOI: https://doi.org/10.4103/2230-8229.108174
American Diabetes Association. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021 Jan; 44(suppl-1): S53-S72. doi: 10.2337/dc21-S005. DOI: https://doi.org/10.2337/dc21-S005
Centers for Disease Control and Prevention. Vaccines and Preventable Diseases: Vaccines for Adults. 2019. [Last cited: 7th Jun 2023]. Available at: https://www.cdc.gov/vaccines/vpd/vaccines-adults.html.
Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008 Dec; 31(12): 2383-90. doi: 10.2337/dc08-0985. DOI: https://doi.org/10.2337/dc08-0985
Yamaoka K and Tango T. Efficacy of lifestyle education to prevent type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetes Care. 2005 Nov; 28(11): 2780-6. doi: 10.2337/diacare.28.11.2780. DOI: https://doi.org/10.2337/diacare.28.11.2780
Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, et al. The Finnish Diabetes Prevention Study (DPS) Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003 Dec; 26(12): 3230-6. doi: 10.2337/diacare.26.12.3230. DOI: https://doi.org/10.2337/diacare.26.12.3230
Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care. 2002 Dec; 25(12): 2165-71. doi: 10.2337/diacare.25.12.2165. DOI: https://doi.org/10.2337/diacare.25.12.2165
Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ. 2007 Feb; 334(7588): 299. doi: 10.1136/bmj.39063.689375.55. DOI: https://doi.org/10.1136/bmj.39063.689375.55
Bowman BA, Gregg EW, Williams DE, Engelgau MM, Jack Jr L. Translating the science of primary, secondary, and tertiary prevention to inform the public health response to diabetes. Journal of Public Health Management and Practice. 2003 Nov; 9: S8-14. doi: 10.1097/00124784-200311001-00002. DOI: https://doi.org/10.1097/00124784-200311001-00002
Garfield SA, Malozowski S, Chin MH, Venkat Narayan KM, Glasgow RE, Green LW, et al. Considerations for diabetes translational research in real-world settings. Diabetes Care. 2003 Sep; 26(9): 2670-4. doi: 10.2337/diacare.26.9.2670. DOI: https://doi.org/10.2337/diacare.26.9.2670
Venkat Narayan KM, Benjamin E, Gregg EW, Norris SL, Engelgau MM. Diabetes translation research: where are we and where do we want to be? Annals of Internal Medicine. 2004 Jun; 140(11): 958-63. doi: 10.7326/0003-4819-140-11-200406010-00037. DOI: https://doi.org/10.7326/0003-4819-140-11-200406010-00037
Glasgow RE, Wagner EH, Kaplan RM, Vinicor F, Smith L, Norman J. If diabetes is a public health problem, why not treat it as one? A population-based approach to chronic illness. Annals of Behavioral Medicine. 1999 Jun; 21(2): 159-70. doi: 10.1007/BF02908297. DOI: https://doi.org/10.1007/BF02908297
Norris SL, Nichols PJ, Caspersen CJ, Glasgow RE, Engelgau MM, Jack Jr L, et al. Increasing diabetes self-management education in community settings: a systematic review. American Journal of Preventive Medicine. 2002 May; 22(4): 39-66. doi: 10.1016/S0749-3797(02)00424-5. DOI: https://doi.org/10.1016/S0749-3797(02)00424-5
Ichiho HM, deBrum I, Kedi S, Langidrik J, Aitaoto N. An assessment of non-communicable diseases, diabetes, and related risk factors in the Republic of the Marshall Islands, Majuro Atoll: a systems perspective. Hawai'i Journal of Medicine & Public Health. 2013 May; 72(5 Suppl 1): 87.
Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 2005 Jan; 293(2): 194-202. doi:10.1001/jama.293.2.194. DOI: https://doi.org/10.1001/jama.293.2.194
Shin HY, Jung KJ, Linton JA, Jee SH. Association between fasting serum glucose levels and incidence of colorectal cancer in Korean men: The Korean Cancer Prevention Study-II. Metabolism. 2014 Oct; 63(10): 1250-6. doi:10.1016/j.metabol.2014.07.006. DOI: https://doi.org/10.1016/j.metabol.2014.07.006
Korean Diabetes Association. 2015 Treatment guideline for diabetes. 2015. [Last cited: 7 Jun 2023]. Available at: https://www.diabetes.or.kr/bbs/?code=eng_treatment&mode=view&number=590&page=1&code=eng_treatment.
Gordon‐Dseagu VL, Shelton N, Mindell JS. Epidemiological evidence of a relationship between type‐1 diabetes mellitus and cancer: a review of the existing literature. International Journal of Cancer. 2013 Feb; 132(3): 501-8. doi: 10.1002/ijc.27703. DOI: https://doi.org/10.1002/ijc.27703
Farr JN, Drake MT, Amin S, Melton III LJ, McCready LK, Khosla S. In vivo assessment of bone quality in postmenopausal women with type 2 diabetes. Journal of Bone and Mineral Research. 2014 Apr; 29(4): 787-95. doi: 10.1002/jbmr.2106. DOI: https://doi.org/10.1002/jbmr.2106
Strachan MW, Deary IJ, Ewing FM, Frier BM. Is type II diabetes associated with an increased risk of cognitive dysfunction: a critical review of published studies. Diabetes Care. 1997 Mar; 20(3): 438-45. doi: 10.2337/diacare.20.3.438. DOI: https://doi.org/10.2337/diacare.20.3.438
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments